Skip to main navigation Skip to search Skip to main content

Determination of vigabatrin and gabapentin in dosage forms and humen plasma using high performance liquid chromotography-mass spectrometry.

Project: RESEARCH PROJECT

Project Details

Description

A simple, rapid, and accurate liquid chromatographic-mass spectrometric method for quantification of vigabatrin (VGB) in human plasma using 4-phenyl-4-aminobutanoic acid as an internal standard (IS) has been developed and validated. The method involves deproteinization of plasma sample with acetonitrile followed by detection of analytes by tandem mass spectrometry. The drug and the IS were chromatographed using XTerra™ C18 column and a mobile phase consisting of acetonitrile/water (50:50 v/v) and 0.025% formic acid, at a flow rate of 0.1 mL/ min. The effluents were detected in multiple reaction monitoring (MRM) mode using MRM transitions m/z 129.57 > 70.99 and m/z 179.7 > 116.92 for VGB and IS, respectively. The method is significantly fast, as the run-cycle time was <3 min run-to-run. The described method was linear over the VGB concentration range of 0.5-10 μg/mL (r > 0.999), with a limit of detection of 0.05 μg/mL. The intra-day coefficient of variation [CV (%)] ranged from 3.84% to 6.53% and the percentage deviation from the nominal value (%DEVs) was in the range of -4.93% to -2.03%. Inter-day CV and %DEVs ranges were 2.78% to 9.15% and -4.91% to 6.67%, respectively. Mean recovery percentage of VGB in spiked human plasma samples was 99.59%. The stability study indicates that VGB in plasma is stable for at least 4 weeks when stored at -20°C. This developed method is significantly important in clinical practice for monitoring VGB plasma levels, particularly in pharmacokinetic studies and bioavailability/bioequivalence studies.

StatusFinished
Effective start/end date1/04/03 → 31/07/04

UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This project contributes towards the following SDG(s):

  1. SDG 7 - Affordable and Clean Energy
    SDG 7 Affordable and Clean Energy

Keywords

  • Vigabatrin
  • Gabapentin
  • Antiepileptics
  • dosage forms
  • humen plasma
  • chromatography
  • mass spectrometry.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.